Narges Hosseininasab (Narges Hosseini Nasab)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Molecular Docking

Cardiovascular Risk Factors

Top Venues

Molecules (Basel, Switzerland)

Molecular diversity

Chemistry & biodiversity

Chemical biology & drug design

This page only lists publications with an associated author ORCID identifier.

Publications

Young Jin Jung, Narges Hosseininasab, Jungjin Park, Soon-Sil Hyun, Jae-Kyung Jung, Jae-Hwan Kwak
Microwave-Promoted Total Synthesis of Puniceloid D for Modulating the Liver X Receptor. Molecules (Basel, Switzerland) 29 (2) (2024)
Young Jin Jung, Narges Hosseininasab, Jungjin Park, Soon-Sil Hyun, Jae-Kyung Jung, Jae-Hwan Kwak
Microwave-Promoted Total Synthesis of Puniceloid D for Modulating the Liver X Receptor. Molecules (Basel, Switzerland) 29 (2) (2024)
Young Jin Jung, Narges Hosseininasab, Jungjin Park, Soon-Sil Hyun, Jae-Kyung Jung, Jae-Hwan Kwak
Microwave-Promoted Total Synthesis of Puniceloid D for Modulating the Liver X Receptor. Molecules (Basel, Switzerland) 29 (2) (2024)
Narges Hosseininasab, Hussain Raza, Young Seok Eom, Fahad Hassan Shah, Jae-Hwan Kwak, Song Ja Kim
Exploring chalcone-sulfonyl piperazine hybrids as anti-diabetes candidates: design, synthesis, biological evaluation, and molecular docking study. Molecular diversity (2024)
Young Jin Jung, Narges Hosseininasab, Jungjin Park, Soon-Sil Hyun, Jae-Kyung Jung, Jae-Hwan Kwak
Microwave-Promoted Total Synthesis of Puniceloid D for Modulating the Liver X Receptor. Molecules (Basel, Switzerland) 29 (2) (2024)
Narges Hosseininasab, Hussain Raza, Young Seok Eom, Mubashir Hassan, Andrzej Kloczkowski, Song Ja Kim
Synthesis and discovery of potential tyrosinase inhibitor of new coumarin-based thiophenyl-pyrazolylthiazole nuclei: In vitro evaluation, cytotoxicity, kinetic, and computational studies. Chemical biology & drug design (2023)
Narges Hosseininasab, Yohan Han, Fahad Hassan Shah, Balasaheb D Vanjare, Song Ja Kim
Synthesis, Biological Evaluation, Migratory Inhibition and Docking Study of Indenopyrazolones as Potential Anticancer Agents. Chemistry & biodiversity 19 (9) (2022)